You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

talquetamab

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed or Refractory Multiple Myeloma Trial (Talquetamab)

Available
  • Relapsed or Refractory Multiple Myeloma
  • Talquetamab
  • (no location specified)
Mar 6, 2023

Multiple Myeloma Trial in Miami (Teclistamab, Talquetamab, Daratumumab SC)

Not yet recruiting
  • Multiple Myeloma
  • Miami, Florida
    University of Miami
Oct 20, 2023

Multiple Myeloma Trial in United States (Talquetamab)

Recruiting
  • Multiple Myeloma
  • Talquetamab
  • Basking Ridge, New Jersey
  • +6 more
Sep 27, 2023

Multiple Myeloma Trial in Worldwide (Talquetamab, Teclistamab, Daratumumab)

Recruiting
  • Multiple Myeloma
  • Talquetamab
  • +2 more
  • Edmonton, Alberta, Canada
  • +12 more
Jan 27, 2023

Hematological Malignancies Trial in Worldwide (Talquetamab)

Recruiting
  • Hematological Malignancies
  • Talquetamab
  • Birmingham, Alabama
  • +14 more
Jul 14, 2022

High-Risk de Novo Multiple Myeloma Trial in Spain (Daratumumab, Bortezomib, Lenalidomide)

Not yet recruiting
  • High-Risk de Novo Multiple Myeloma
  • Badalona, Spain
  • +9 more
Apr 27, 2023

Relapsed/ Refractory Multiple Myeloma Trial in Worldwide (Talquetamab, Teclistamab, PD-1 Inhibitor)

Recruiting
  • Relapsed/ Refractory Multiple Myeloma
  • Talquetamab
  • +2 more
  • Denver, Colorado
  • +19 more
Jan 27, 2023

Multiple Myeloma Trial in Japan (Talquetamab)

Recruiting
  • Multiple Myeloma
  • Talquetamab
  • Kamakura-shi, Japan
  • +5 more
Aug 11, 2022

Relapsed/ Refractory Multiple Myeloma Trial in Worldwide (Talquetamab, Belantamab Mafodotin)

Not yet recruiting
  • Relapsed/ Refractory Multiple Myeloma
  • Talquetamab
  • Belantamab Mafodotin
  • Fayetteville, Arkansas
  • +75 more
Aug 11, 2022

Hematological Malignancies Trial in Worldwide (Talquetamab)

Recruiting
  • Hematological Malignancies
  • Talquetamab
  • Birmingham, Alabama
  • +82 more
Aug 11, 2022

Relapsed or Refractory Multiple Myeloma Trial in Worldwide (Talquetamab, Daratumumab, Pomalidomide)

Not yet recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Talquetamab
  • +3 more
  • Tucson, Arizona
  • +191 more
Aug 11, 2022